Readability user tests

Readability user tests in English, German and all other official European Union languages

More information

Packungsbeilage mit winziger Schrift und einer darüber gehaltenen Lupe


Bridging of package inserts for all approval procedures

More information

Die London Tower Bridge als Symbol für ein Bridging von zwei oder mehren Packungsbeilagen


Layout and design for any kind of medical information

More information

Medical writing

Creation and optimisation of each type of medical information

More information

Usability tests

Correct use of application devices

More information


Planning, coordination, realisation and evaluation

More information

Reagenzgläser und Messbecher in bunten Farben

Our service for you

We create and design comprehensible and concise patient information leaflets and other medical information for Europe, USA and Canada; as well as conducting readability user tests and usability tests.

In providing this service, we apply our extensive and multi-layered study portfolio to medicinal and healthcare issues; the efficacy of which has been confirmed by numerous publications.

Our published research results and recommendations have been implemented in various European Union directives and guidelines.

Call us for readability user tests, usability tests and medical information!
Phone: +49 3641 549396   

Extensive research published concerning the QRD template

Dr. Anna Wolf finalised her extensive work in February 2015 concerning the QRD template of the European Union, under PAINT-Consult’s supervision at the University of Bonn. 

This dissertation (PDF) contains the following main investigations:

  • development of the QRD template from 1996 up to the present day
    Main results: Many improvements as a result of version 8; however, extreme text increase over the years. See sections 4.1 and 4.2.
  • comparison of templates used in EU and non-EU countries
    Main result: Many similarities in structure and content between different countries. See sections 4.3 to 4.5.
  • implementation of the QRD template based on an analysis of package leaflets of all centrally approved medicines
    Main result: Quick implementation through the pharmaceutical companies; however, the QRD template is one of the main reasons for the ongoing text increase in package leaflets. See section 4.6.
  • readability tests with 241 participants in the United Kingdom and Germany of QRD templates 7.3.1, 8 and a model template containing only 200 words. The model template investigated was developed by PAINT-Consult and successfully investigated in another QRD template study published in the PharmInd journal (PDF)
    Results include:
    Version 8 is an improvement
    of version 7.3.1; however, the shorter model template has significant advantages compared to both QRD templates. Relevant disadvantages were not found. The current side effect frequency explanation shows significant comprehensibility problems - particularly overestimations - compared to the EMA version published 2007. Deletion of the MAH representative list is a key patient request. See sections 4.7 to 4.10.


Last update: 03.05.2022

  +49 3641 549396